Internal Medicine, Pulmonary Disease · Wyomissing, PA
NPI
1063766574
Since 2012
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2608 Keiser Blvd
Wyomissing, PA, 19610
Phone (610) 685-5864
Groups this clinician bills Medicare through
Medicare paid, 2024
$196K
3,007 services
Medicare patients, 2024
695
Average age 75
Drug cost, 2024
$1.8M
2,623 prescriptions
Company payments, 2025
$1,062
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pallak Agarwal was code 99233 (hospital e&m - subsequent), 533 times for 242 patients. In total Pallak Agarwal billed 3,007 services in 42 codes, and Medicare paid $196K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 533 | 242 | $80.63 | $43K |
| 96160 E&M - Miscellaneous | Office | 475 | 230 | $1.78 | $845 |
| J0517 Injection, benralizumab, 1 mg | Office | 450 | 11 | $130.38 | $59K |
| 99214 Office E&M - Established | Office | 343 | 204 | $79.81 | $27K |
| 99223 Hospital E&M - Initial | Facility | 170 | 168 | $115.58 | $20K |
| 99213 Office E&M - Established | Office | 97 | 89 | $55.81 | $5,414 |
| 99291 Critical Care E&M | Facility | 93 | 36 | $146.61 | $14K |
| 94729 Pulmonary Function Testing | Office | 73 | 73 | $36.26 | $2,647 |
| 94727 Pulmonary Function Testing | Office | 72 | 72 | $28.61 | $2,060 |
| 94060 Pulmonary Function Testing | Office | 53 | 53 | $24.83 | $1,316 |
| 96372 Injection Administration | Office | 45 | 24 | $8.23 | $371 |
| 94010 Pulmonary Function Testing | Office | 21 | 21 | $17.43 | $366 |
| 31624 Bronchoscopy | Facility | 14 | 14 | $68.04 | $953 |
| 99232 Hospital E&M - Subsequent | Facility | 14 | 12 | $54.20 | $759 |
| 94010 Pulmonary Function Testing | Facility | 12 | 12 | $5.12 | $61.49 |
By year: 2022 $140K for 2,538 services; 2023 $192K for 3,099 services; 2024 $196K for 3,007 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pallak Agarwal prescribed most often to Medicare patients was Montelukast Sodium, with 344 prescriptions and refills. In total Pallak Agarwal wrote 2,623 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 344 | 795 | 87 | $6,083 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 335 | 459 | 104 | $13K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 318 | 508 | 71 | $312K |
| Prednisone Generic | 152 | 186 | 87 | $486 |
| Breo Ellipta Fluticasone/Vilanterol | 145 | 251 | 38 | $95K |
| Xolair Omalizumab | 130 | 130 | 11 | $601K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 118 | 196 | 30 | $25K |
| Azithromycin Generic | 94 | 131 | 56 | $776 |
| Spiriva Respimat Tiotropium Bromide | 76 | 116 | 19 | $58K |
| Fluticasone Propionate Generic | 73 | 152 | 20 | $801 |
| Ventolin Hfa Albuterol Sulfate | 70 | 86 | 22 | $5,898 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 63 | 110 | 17 | $68K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 63 | 96 | 22 | $17K |
| Pantoprazole Sodium Generic | 49 | 114 | 15 | $415 |
| Symbicort Budesonide/Formoterol Fumarate | 45 | 59 | 19 | $13K |
Brand drugs: 1,464 claims; generic drugs: 1,159 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pallak Agarwal $1,062 ($1,062 in general payments such as food, travel and fees) from 14 companies. The largest payer was GlaxoSmithKline, LLC. with $403.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 16 | $403 |
| Insmed, Inc. INSM | 6 | $142 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $99.99 |
| Genzyme Corporation SNY | 4 | $90.8 |
| Verona Pharma, Inc. VRNA | 2 | $49.16 |
| Merck Sharp & Dohme LLC MRK | 3 | $48.76 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $48.56 |
| Genentech USA, Inc. ROG.SW | 2 | $35.33 |
| Viatris Specialty LLC | 1 | $34.78 |
| Axsome Therapeutics, Inc. AXSM | 2 | $31.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.